Get started
EBOS GROUP LIMITEDEBOS GROUP LIMITEDEBOS GROUP LIMITED

EBOS GROUP LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

EBO chart


Full chart

EBO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.58 B‬ AUD
Dividend yield (indicated)
3.17%
Price to earnings Ratio (TTM)
24.57
Basic EPS (TTM)
1.40 AUD
Net income (FY)
‪268.17 M‬ AUD
Revenue (FY)
‪13.03 B‬ AUD
Shares float
‪155.89 M‬
Beta (1Y)
0.65

Employees


Employees (FY)
‪5.2 K‬
Change (1Y)
+200 +4.00%
Revenue / Employee (1Y)
‪1.67 M‬ AUD
Net income / Employee (1Y)
‪34.38 K‬ AUD

About EBOS GROUP NPV


Sector
Health Technology
Industry
Medical Specialties
CEO
John Cullity
Website
ebos.co.nz
Headquarters
Docklands
Founded
2013
ISIN
NZEBOE0001S6
FIGI
BBG005MBRML8
EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. It operates through the following segments: Healthcare, Animal Care, and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare and wholesale activities. The Animal Care segment sells animal care products in a range of sectors, own brands, retail and wholesale activities. The Corporate segment includes net funding costs and central administration expenses. The company was founded on September 11, 1922 and is headquartered in Docklands, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

EBO news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EBO is 33.68 AUD — it has decreased by −0.21% in the past 24 hours. Watch EBOS GROUP LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange EBOS GROUP LIMITED stocks are traded under the ticker EBO.
EBO stock has fallen by −0.56% compared to the previous week, the month change is a 1.99% rise, over the last year EBOS GROUP LIMITED has showed a 1.32% increase.
We've gathered analysts' opinions on EBOS GROUP LIMITED future price: according to them, EBO price has a max estimate of 39.00 AUD and a min estimate of 27.38 AUD. Watch EBO chart and read a more detailed EBOS GROUP LIMITED stock forecast: see what analysts think of EBOS GROUP LIMITED and suggest that you do with its stocks.
EBO reached its all-time high on Jan 17, 2023 with the price of 45.77 AUD, and its all-time low was 8.00 AUD and was reached on Oct 17, 2014. View more price dynamics on EBO chart.
See other stocks reaching their highest and lowest prices.
EBO stock is 1.67% volatile and has beta coefficient of 0.65. Track EBOS GROUP LIMITED stock price on the chart and check out the list of the most volatile stocks — is EBOS GROUP LIMITED there?
Today EBOS GROUP LIMITED has the market capitalization of ‪6.58 B‬, it has increased by 0.20% over the last week.
Yes, you can track EBOS GROUP LIMITED financials in yearly and quarterly reports right on TradingView.
EBOS GROUP LIMITED is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
EBO earnings for the last half-year are 0.78 AUD per share, whereas the estimation was 0.77 AUD, resulting in a 2.35% surprise. The estimated earnings for the next half-year are 0.71 AUD per share. See more details about EBOS GROUP LIMITED earnings.
EBOS GROUP LIMITED revenue for the last half-year amounts to ‪6.61 B‬ AUD, despite the estimated figure of ‪6.50 B‬ AUD. In the next half-year revenue is expected to reach ‪5.85 B‬ AUD.
EBO net income for the last half-year is ‪133.74 M‬ AUD, while the previous report showed ‪136.52 M‬ AUD of net income which accounts for −2.03% change. Track more EBOS GROUP LIMITED financial stats to get the full picture.
EBOS GROUP LIMITED dividend yield was 3.84% in 2024, and payout ratio reached 81.00%. The year before the numbers were 3.21% and 81.14% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has ‪5.20 K‬ employees. See our rating of the largest employees — is EBOS GROUP LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EBOS GROUP LIMITED EBITDA is ‪604.50 M‬ AUD, and current EBITDA margin is 4.64%. See more stats in EBOS GROUP LIMITED financial statements.
Like other stocks, EBO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EBOS GROUP LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EBOS GROUP LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EBOS GROUP LIMITED stock shows the neutral signal. See more of EBOS GROUP LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.